Loading...
Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab
Hemolytic-uremic syndrome (HUS) is the triad of microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and acute kidney injury (AKI); the main cause of multi-organ failure is related to thrombotic microangiopathy (TMA). Atypical HUS (aHUS) is a disease of uncontrolled complement activation asso...
Saved in:
| Published in: | Cureus |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Cureus
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5400517/ https://ncbi.nlm.nih.gov/pubmed/28439485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1111 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|